Nicotine facilitates long-term potentiation induction in oriens-lacunosum moleculare cells via Ca2+ entry through non-alpha7 nicotinic acetylcholine receptors.

The European Journal of Neuroscience
Yousheng JiaK Sumikawa

Abstract

Hippocampal inhibitory interneurons have a central role in the control of network activity, and excitatory synapses that they receive express Hebbian and anti-Hebbian long-term potentiation (LTP). Because many interneurons in the hippocampus express nicotinic acetylcholine receptors (nAChRs), we explored whether exposure to nicotine promotes LTP induction in these interneurons. We focussed on a subset of interneurons in the stratum oriens/alveus that were continuously activated in the presence of nicotine due to the expression of non-desensitizing non-alpha7 nAChRs. We found that, in addition to alpha2 subunit mRNAs, these interneurons were consistently positive for somatostatin and neuropeptide Y mRNAs, and showed morphological characteristics of oriens-lacunosum moleculare cells. Activation of non-alpha7 nAChRs increased intracellular Ca(2+) levels at least in part via Ca(2+) entry through their channels. Presynaptic tetanic stimulation induced N-methyl-D-aspartate receptor-independent LTP in voltage-clamped interneurons at -70 mV when in the presence, but not absence, of nicotine. Intracellular application of a Ca(2+) chelator blocked LTP induction, suggesting the requirement of Ca(2+) signal for LTP induction. The induction...Continue Reading

References

Jan 1, 1995·Neuropharmacology·J P Pin, R Duvoisin
Oct 1, 1994·Neuroscience Research·S SawadaT Ohno-Shosaku
Jun 1, 1993·Drug and Alcohol Dependence·J E HenningfieldE D London
Jan 7, 1993·Nature·T V Bliss, G L Collingridge
Jan 1, 1996·Hippocampus·T F Freund, G Buzsáki
Sep 18, 1997·Neuroscience Research·S HamidJ D Stephenson
Sep 2, 1998·Psychopharmacology·E D Levin, B B Simon
Jun 28, 2001·Physiological Reviews·J LermaJ C López-García
Jul 12, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y PerezJ C Lacaille
Sep 17, 2002·The Journal of Physiology·M J GilliesM A Whittington
Nov 19, 2002·Journal of Neurobiology·Edward D Levin
Feb 21, 2003·Nature·Thomas KlausbergerPeter Somogyi
Dec 13, 2003·Cell Calcium·Sergio Fucile
Dec 16, 2003·The Journal of Physiology·Valérie LapointeJean-Claude Lacaille
May 14, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yanhua H HuangDwight E Bergles
Oct 23, 2004·The Journal of Physiology·Gianmaria Maccaferri
Nov 13, 2004·The Journal of Physiology·Peter Somogyi, Thomas Klausberger
Jan 28, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lisa TopolnikJean-Claude Lacaille
Jun 4, 2005·The Journal of Physiology·Dmitriy Fayuk, Jerrel L Yakel
Aug 24, 2005·The European Journal of Neuroscience·Yoshihiko YamazakiKatumi Sumikawa
Oct 29, 2005·The Journal of Comparative Neurology·Katsuyoshi IshiiKatumi Sumikawa
Oct 3, 2006·Annual Review of Pharmacology and Toxicology·John A Dani, Daniel Bertrand
Dec 13, 2006·The European Journal of Neuroscience·Yoshihiko YamazakiKatumi Sumikawa
Jan 16, 2007·Molecular Neurobiology·Thomas J Gould

❮ Previous
Next ❯

Citations

Nov 20, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Nibaldo C InestrosaMarco Fuenzalida
Aug 27, 2013·Neurobiology of Learning and Memory·Thomas J Gould, Prescott T Leach
Oct 9, 2012·Nature Neuroscience·Richardson N LeãoKlas Kullander
Dec 4, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Elizabeth Nicholson, Dimitri M Kullmann
May 3, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shahrdad LotfipourJim Boulter
Apr 22, 2014·Neurobiology of Aging·Katja S KrokerCornelia Dorner-Ciossek
Jul 15, 2015·The International Journal of Neuropsychopharmacology·Paula L Vieira-BrockAnnette E Fleckenstein
Sep 8, 2011·Journal of Pharmacological Sciences·Kazuhiro KurokawaSeitaro Ohkuma
Jul 25, 2015·Biochemical Pharmacology·Danielle John, Darwin K Berg
May 11, 2016·Scientific Reports·Jingchun ChenUNKNOWN FTND meta-analysis group
Feb 7, 2012·The European Journal of Neuroscience·Lisa Topolnik
Jan 6, 2021·Progress in Neurobiology·Karim A Alkadhi
Oct 27, 2020·Frontiers in Cellular Neuroscience·Nicholas M BannonMaxim Volgushev
Aug 5, 2021·Proceedings of the National Academy of Sciences of the United States of America·James DelormeSara J Aton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.